Immediate Impact
22 from Science/Nature 65 standout
Citing Papers
Tumour vasculature at single-cell resolution
2024 StandoutNature
Theranostic Fluorescent Probes
2024 Standout
Works of S. Seeber being referenced
A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors
2003
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Seeber | 255 | 156 | 157 | 54 | 432 | |
| Yan Wu | 184 | 140 | 107 | 30 | 425 | |
| Paule Augereau | 214 | 127 | 98 | 45 | 385 | |
| Jane C. Wright | 210 | 91 | 142 | 42 | 484 | |
| Krementz Et | 262 | 85 | 109 | 44 | 469 | |
| Thomas Newsom-Davis | 195 | 110 | 230 | 41 | 499 | |
| Paloma Martín-Martorell | 273 | 180 | 78 | 27 | 410 | |
| Eleni Zografos | 222 | 107 | 175 | 40 | 463 | |
| Marye J. Boers‐Sonderen | 332 | 112 | 189 | 42 | 499 | |
| Maria Gonidi | 142 | 132 | 184 | 28 | 453 | |
| Gunta Purkalne | 180 | 117 | 148 | 29 | 411 |
All Works
Login with ORCID to disown or claim papers
Loading papers...